| Minati D Swofford, | |
|
2101 Jackson St, Ste 118, Anderson, IN 46016-4386 | |
| (765) 683-3160 | |
| (765) 646-8367 |
| Full Name | Minati D Swofford |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 37 Years |
| Location | 2101 Jackson St, Anderson, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346237476 | NPI | - | NPPES |
| 100475600 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 01042478A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension St Vincent Anderson | Anderson, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mina Swofford, M.d. P.c | 8224935234 | 2 |
News Archive
Research led by the University of Adelaide has resulted in new insights into clinical depression that demonstrate there cannot be a "one-size-fits-all" approach to treating the disease.
Intensified, BNP-guided therapy was no more effective than a standard, symptom-guided approach in elderly heart failure patients in reducing the number of deaths and all-cause hospitalisations. However, the response to this intervention differed significantly between patients aged 60-74 years and those aged ¡Ý75 years. This indicates the need for specific data in this large subset of very old heart failure patients who have been largely excluded from large treatment trials.
Immune Pharmaceuticals, Inc. announced today that it has submitted an Investigational New Drug Application in the U.S. to expand recruiting for its first in class lead product candidate, Bertilimumab, for the treatment of Bullous Pemphigoid (BP).
Tahitian Noni International announced that, unlike the flavonoids and carotenoids in major superfruit juices that degrade rapidly, the iridoids in Tahitian Noni® Bioactive Beverages™ are found to be extremely stable, even after processing.
› Verified 8 days ago
| Entity Name | Mina Swofford, M.d. P.c |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326250499 PECOS PAC ID: 8224935234 Enrollment ID: O20031217000875 |
News Archive
Research led by the University of Adelaide has resulted in new insights into clinical depression that demonstrate there cannot be a "one-size-fits-all" approach to treating the disease.
Intensified, BNP-guided therapy was no more effective than a standard, symptom-guided approach in elderly heart failure patients in reducing the number of deaths and all-cause hospitalisations. However, the response to this intervention differed significantly between patients aged 60-74 years and those aged ¡Ý75 years. This indicates the need for specific data in this large subset of very old heart failure patients who have been largely excluded from large treatment trials.
Immune Pharmaceuticals, Inc. announced today that it has submitted an Investigational New Drug Application in the U.S. to expand recruiting for its first in class lead product candidate, Bertilimumab, for the treatment of Bullous Pemphigoid (BP).
Tahitian Noni International announced that, unlike the flavonoids and carotenoids in major superfruit juices that degrade rapidly, the iridoids in Tahitian Noni® Bioactive Beverages™ are found to be extremely stable, even after processing.
› Verified 8 days ago
| Entity Name | University Dermatology Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033159405 PECOS PAC ID: 0042204059 Enrollment ID: O20040413000478 |
News Archive
Research led by the University of Adelaide has resulted in new insights into clinical depression that demonstrate there cannot be a "one-size-fits-all" approach to treating the disease.
Intensified, BNP-guided therapy was no more effective than a standard, symptom-guided approach in elderly heart failure patients in reducing the number of deaths and all-cause hospitalisations. However, the response to this intervention differed significantly between patients aged 60-74 years and those aged ¡Ý75 years. This indicates the need for specific data in this large subset of very old heart failure patients who have been largely excluded from large treatment trials.
Immune Pharmaceuticals, Inc. announced today that it has submitted an Investigational New Drug Application in the U.S. to expand recruiting for its first in class lead product candidate, Bertilimumab, for the treatment of Bullous Pemphigoid (BP).
Tahitian Noni International announced that, unlike the flavonoids and carotenoids in major superfruit juices that degrade rapidly, the iridoids in Tahitian Noni® Bioactive Beverages™ are found to be extremely stable, even after processing.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Minati D Swofford, 2101 Jackson St, Ste 118, Anderson, IN 46016-4386 Ph: (765) 683-3160 | Minati D Swofford, 2101 Jackson St, Ste 118, Anderson, IN 46016-4386 Ph: (765) 683-3160 |
News Archive
Research led by the University of Adelaide has resulted in new insights into clinical depression that demonstrate there cannot be a "one-size-fits-all" approach to treating the disease.
Intensified, BNP-guided therapy was no more effective than a standard, symptom-guided approach in elderly heart failure patients in reducing the number of deaths and all-cause hospitalisations. However, the response to this intervention differed significantly between patients aged 60-74 years and those aged ¡Ý75 years. This indicates the need for specific data in this large subset of very old heart failure patients who have been largely excluded from large treatment trials.
Immune Pharmaceuticals, Inc. announced today that it has submitted an Investigational New Drug Application in the U.S. to expand recruiting for its first in class lead product candidate, Bertilimumab, for the treatment of Bullous Pemphigoid (BP).
Tahitian Noni International announced that, unlike the flavonoids and carotenoids in major superfruit juices that degrade rapidly, the iridoids in Tahitian Noni® Bioactive Beverages™ are found to be extremely stable, even after processing.
› Verified 8 days ago
Dr. David L Martin, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2101 Jackson St, Ste 201, Anderson, IN 46016 Phone: 765-649-0161 Fax: 765-644-4995 |